Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Tracon Pharma Common

TRADE

NASDAQ: TCONHealthcare / Biotechnology / USA
2.55-0.10-3.77%Vol 25 0111Y Perf 10.87%
Jul 19th, 2018 16:00
BID2.55 ASK2.60
Open2.65 Previous Close2.65
Pre-Market- After-Trading2.55
 - -%  - -%
Target Price
5.75 
Analyst Rating
Moderate Buy 2.00
Potencial %
125.49 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★★     50.51
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)45 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
28.21 
Earnings Date
14th Aug 2018

Today's Price Range

2.552.65

 

52wk Range

2.003.95

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-12.07%
3 Months
-7.27%
6 Months
-8.93%
1 Year
10.87%
3 Years
-80.58%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
TCON2.55-0.1000-3.77
AAPL191.881.48000.78
GOOG1 186.96-8.9200-0.75
MSFT104.40-0.7200-0.68
XOM82.01-0.2100-0.26
WFC56.33-0.2400-0.42
JNJ125.94-1.8600-1.46
FB208.09-1.2700-0.61
GE13.73-0.0200-0.15
JPM109.89-1.6400-1.47
...

TickerPriceChg.%52 Week High
SNA173.299.50185.47
DOV78.125.3088.11
DHR103.204.47106.08
SCG40.203.5368.35
SWN5.363.476.72
WMB28.693.3533.67
M38.963.3441.33
SIG60.663.3277.94
IBM149.243.27171.13
AZO716.173.19797.89
PDCO22.983.1443.20
ORLY299.233.00300.07
D72.002.9385.30
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.10
Current Ratio 4.20
Long Term Debt to Total Capital 0.13
Total Debt to Equity 0.16
Interest Coverage -93.90
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-175.00
EBITDA Margin-174.70
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.85
PS Ratios 7.51
Price to Cash Flow 74.30
Price to Free Cash Flow -10.90
Cash Flow Per Share -0.69
Price to Tangible Book1.85
Book Value per Share1.43
Enterprise Value (in ths.)23 041
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)1 149.39
ROE last 12 Months -58.82
Return on Assets (5Y Avg) -34.68
ROA last 12 Months -37.72
Return on Capital (5Y Avg) -
ROC last 12 Months -51.24
Return on invested Capital Q -22.71
Return on invested Capital Y-63.44
Assets Turnover0.20
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 498
Revenue per Share 0.35
Revenue Growth 3 Years 2.62
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.33-0.46-39.39
Q04 2017-0.45-0.3717.78
Q03 2017-0.250.07128.00
Q02 2017-0.53-0.4024.53
Q01 2017-0.47-0.446.38
Q04 2016-0.45-0.450.00
Q03 2016-0.58-0.4817.24
Q02 2016-0.61-0.68-11.48
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.3025.00Positive
9/2018 QR-0.2824.32Positive
12/2018 FY-1.2428.74Positive
12/2019 FY-0.3546.97Positive
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.30
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume25 011
Shares Outstanding (in ths.)17 750
Trades Count66
Dollar Volume61 688
Avg. Volume173 236
Avg. Weekly Volume38 404
Avg. Monthly Volume71 916
Avg. Quarterly Volume126 146

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
1.67

There are no comments yet.

News

x